
Evidence separated properly
Human, animal, laboratory, regulatory and formulation evidence stay distinct, so indirect evidence is not presented as direct clinical proof.
A peptide evidence platform designed to make complicated research understandable without stripping away the uncertainty.

WhichPeps is built for someone discovering peptides today and for the reader who wants to inspect the study-level details.
Peptide information online often mixes published research, supplier claims, community experience and speculation. WhichPeps separates those layers so readers can tell what was studied, in whom, with what formulation and with what result.
WhichPeps publishes its methodology, editorial standards, source records and correction history so readers can trace how conclusions are formed and changed. Named scientific or clinical reviewers are credited only where they have genuinely reviewed the material.

Human, animal, laboratory, regulatory and formulation evidence stay distinct, so indirect evidence is not presented as direct clinical proof.

Primary studies, regulators, study limitations, review dates and correction routes remain visible so readers can check how a conclusion was formed.

WhichPeps does not sell peptides or rank suppliers. Negative findings, uncertainty and corrections stay visible rather than being hidden behind promotional language.
Use these routes to browse the evidence library, methodology tools and specialist research resources directly.
Find authoritative sterile-equipment, needle/syringe programme and sharps-disposal resources by region.
Open resource →Go directly to study-level records. Human, animal, laboratory and regulatory evidence stay distinguishable.
Open resource →Choose the evidence question you want to answer and jump to the right WhichPeps research surface.
Open resource →Create a printable evidence brief for up to five compounds using the same structured summaries as the public pages.
Open resource →Start with the outcome you care about. Each map points to relevant compounds without pretending that evidence transfers between different populations, routes or endpoi…
Open resource →Inspect retractions, corrections, registry problems and other integrity signals that materially change how peptide evidence should be interpreted.
Open resource →What COAs, identity testing, purity assays, sterility testing and product traceability can and cannot establish.
Open resource →Browse negative findings, key limitations and unanswered evidence questions across peptide and related-compound research.
Open resource →A transparent route into material evidence updates, corrections and regulatory-status changes.
Open resource →Plain-language definitions for the evidence terms and classifications used across WhichPeps.
Open resource →Browse product- and jurisdiction-specific regulatory status across the WhichPeps evidence library.
Open resource →